Pharmacokinetics of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZG, NSC 224070) during a phase I clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/2138904

Download in:

View as

General Info

PMID
2138904